DB27995InvestigationalVaccines
ZR202-CoV is a biologic drug. ZR202-CoV is under investigation in clinical trial NCT05490108 (Evaluation of Safety and Immunogenicity of the Recombinant ZR202-CoV and ZR202a-CoV Vaccines in Adults.).
- Code names
- 202-CoV · ZR-202-CoV
What you can answer from here — as of December 21, 2025
Which companies are running trials of ZR202-CoV, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account